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Abstract
To investigate the necessity and potential application of structural genes for expressing heterogenous genes from
Sindbis virus-derived vector, the DNA-based expression vector pVaXJ was constructed by placing the recombinant
genome of sindbis-like virus XJ-160 under the control of the human cytomegalovirus (CMV) promoter of the
plasmid pVAX1, in which viral structural genes were replaced by a polylinker cassette to allow for insertion of
heterologous genes. The defect helper plasmids pVaE or pVaC were developed by cloning the gene of
glycoprotein E3E26KE1 or capsid protein of XJ-160 virus into pVAX1, respectively. The report gene cassette pVaXJ-
EGFP or pV-Gluc expressing enhanced green fluorescence protein (EGFP) or Gaussia luciferase (G.luc) were
constructed by cloning EGFP or G.luc gene into pVaXJ. EGFP or G.luc was expressed in the BHK-21 cells co-
transfected with report gene cassettes and pVaE at levels that were comparable to those produced by report gene
cassettes, pVaC and pVaE and were much higher than the levels produced by report gene cassette and pVaC,
suggesting that glycoprotein is enough for Sindbis virus-derived DNA vector to express heterogenous genes in
host cells. The method of gene expression from Sindbis virus-based DNA vector only co-transfected with envelop E
gene increase the conveniency and the utility of alphavirus-based vector systems in general.
Findings
The concept that alphaviruses can be developed as
expression vectors was first established by Xiong et al.
[1]. Since then, Sindbis virus (SINV), a member of
alphavirus, has been developed as vectors for the expres-
sion of heterologous gene [2-4], gene therapy and vac-
cine application [5-8]. Sindbis virus genome is a single
strand of positive-sense RNA of approximately 12 kb
which is capped at the 5’ terminus and polyadenylated
at the 3’ terminus [9]. The 5’ two-thirds of this RNA
encode the nonstructural proteins (nsP1 through 4).
The 3’ one-third is initially translated as a polyprotein
(NH2-C-E3-E2-6K-E1-COOH) that is processed co- and
posttranslationally to produce the structural proteins
(SPs) (capsid, El and E2). In infected cells, the virion
structural proteins are translated from a subgenomic
mRNA (26S RNA) and produced by transcription of
genome-length complementary (minus) strand from a
highly active subgenomic promoter. Since the nonstruc-
tural protein genes and the structural protein genes are
expressed from two different mRNAs, they may be
expressed independently of one another [10]. Thus, the
high levels of expression of heterologous products are
achieved when the viral structural genes are replaced by
the heterologous coding sequences. Such recombinant
vectors are self-replicating (replicons) and can be intro-
duced into cells as naked RNA or plasmid DNA.
As a Sindbis-like virus, XJ-160 virus (GenBank No.
AF103728) was isolated from a pooled sample of Ano-
pheles mosquitoes collected in Xinjiang, China, in 1990
[11]. Recombinant plasmid pBR-XJ160 is an infectious
full-length cDNA clone of XJ-160 virus, from which res-
cued virus BR-XJ160 can be obtained by transcription in
vitro and transfection. The BR-XJ160 virus raised in BHK-
21 cells was indistinguishable from the XJ-160 virus in its
biological properties, including its plaque morphology,
growth kinetics and suckling mouse neurovirulence [12].
On basis of pBR-XJ160, the effects of the substitutions of
169 Lys and 173Thr in nonstructural protein 1 (nsP1) as
well as nsP2-726 Pro on the infectivity and pathogenesis
of Sindbis virus have been investigated [13,14]. We have
also confirmed the essential role of E2 glycoprotein, espe-
cially the domain of 145-150 aa, in Sindbis virus infection
through the interaction with cellular heparan sulfate
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[15,16]. In addition, we have developed XJ-160 virus-based
RNA vector system, including replicon vector pBRepXJ, a
defective helper (DH) plasmid (pBR-H) and the packaging
cell lines (PCLs) [17,18].
The conventional approaches producing infectious
Sindbis virus RNA and its derived complementary vec-
tors were restricted primarily to in vitro transcription of
cDNA clones from a bacteriophage RNA polymerase
promoter, followed by transfection into permissive cells.
Compared with this method, alphavirus replication can
also be initiated by transfection of plasmid DNA [4,19].
In this case, full-length 5’-capped RNAs are transcribed
in the nucleus using a polymerase II promoter and
transported to the cytoplasm, the site of primary transla-
tion and RNA amplification. Therefore, there is no need
for in vitro transcription and mRNA capping as required
for the transfection of previously described Sindbis
virus-derived RNA vectors. For the construction of XJ-
160 virus-based DNA vector, the recombinant genome
of XJ-160 virus was placed under the control of the
human cytomegalovirus (CMV) promoter of the plasmid
pVAX1 (Invitrogen, USA), in which viral structural
genes were replaced by the sequence of multiple cloning
site (MCS) to allow for insertion of heterologous genes
(Figure 1). The virus non-structural gene sequence (1-
7562nt), divided into three fragments XJ1 (1-2527nt),
Figure 1 Construction of pVaXJ vector derived from XJ-160 virus.
Zhu et al. Virology Journal 2011, 8:344
http://www.virologyj.com/content/8/1/344
Page 2 of 5
XJ2 (2527-5161nt) and XJ3 (5161-7562nt), was inserted
into pVAX1 between unique NheI and NotI sites. The
sequence of MCS under the control of subgenomic pro-
moter contains several unique enzyme recognition sites,
including NotI, PvuI, FseI, PacI and AscI. And the DNA
vector derived from XJ-160 virus in this study was
designated as pVaXJ. In addition, two DH plasmids
were developed by cloning the gene of glycoprotein
E3E26KE1 (8355-11297nt) or capsid protein (7563-
8354nt) of XJ-160 virus into pVax1, respectively.
To perform the qualitative and quantitative identifica-
tion of pVaXJ, the report gene cassettes expressing
either green fluorescence protein (EGFP) or Gaussia
luciferase (G.luc) were constructed. In brief, the EGFP
expression cassette pVaXJ-EGFP was constructed by
inserting EGFP gene from the vector pEGFP-N1 (Invi-
trogen, USA) into the vector pVaXJ by digestion with
NotI and AscI. Similarly, G.luc gene was amplified from
pCMV-GLUC-1 vector (NEB, USA), and was inserted
into pVaXJ with FseI and AscI.The G.luc expression cas-
sette was designated as pV-Gluc. To investigate the
functional activity of pVaXJ, and to determine whether
both DH vectors are necessary to express report genes,
BHK-21 cells were co-transfected with pVaXJ-EGFP
+pVaE+pVaC, pVaXJ-EGFP+pVaE or pVaXJ-EGFP
+pVaC, respectively. And the expressions of EGFP were
observed through scanned by an inverted fluorescence
microscope (400×). As can be seen in Figure 2, the
green fluorescence was observed from all of three
groups of BHK-21 cells at 24 hours post-cotransfection.
In contrast, the control was negative. These results
clearly demonstrated that XJ-160 virus-based DNA vec-
tor (pVaXJ) was able to efficiently express report genes
by co-transfection with pVaE, pVaC or both of them,
respectively. Importantly, the level of specific fluores-
cence from the BHK-21 cells co-transfected with
pVaXJ-EGFP+pVaE was comparable to that produced
by pVaXJ-EGFP+pVaC+pVaE, and obviously higher
than that from the BHK-21 cells co-transfected with
pVaXJ-EGFP and pVaC, suggesting that glycoprotein
plays a more important role than capsid protein in
expressing heterogenous gene from pVaXJ vector.
For further comparing the necessity and potential
application of structural genes, expression of G.luc gene
was detected after BHK-21 cells were co-transfected
with pV-Gluc, pV-Gluc+pVaE+pVaC, pV-Gluc+pVaE or
pV-Gluc+pVaC, respectively. Gluc assay was performed
by Gaussia Luciferase Assay System (Promega) following
the manufacturer’s instructions. As shown in Figure 3,
G.luc gene was efficiently expressed in all groups of
BHK-21 cells except that transfected with pV-Gluc plas-
mid, indicating that either glycoprotein or capsid protein
is important for pVaXJ to express report genes. Interest-
ingly, the activity of G.luc observed from the BHK-21
transfected with pV-Gluc+pVaE was much higher than
that from the BHK-21 cells co-transfected with pV-Gluc
+pVaE+pVaC, whose expression efficiency was similar
to that of the BHK-21 cells transfected with pV-Gluc
+pVaC. As mentioned earlier, the alphavirus particles
are surrounded be a lipid bilayer containing envelop gly-
coprotein heterodimer. And the capsid subunits com-
plex with the genome RNA to form a nucleocapsid
acquiring the lipid envelop with embedded viral glyco-
proteins. In addition, the capsid protein of alphaviruses
may be important factor in the inhibitionof host cell
protein synthesis. Therefore, compared with capsid, gly-
coprotein plays a more important role in packaging
virus particles or virus like particles, and is enough for
Figure 3 Expression of G.luc on BHK-21cells. BHK-21 cells were
cotransfected with pV-Gluc, pV-Gluc +pVaE, pV-Gluc +pVaC or pV-
Gluc +pVaE +pVaC, respectively. Gluc assay was performed by
Gaussia Luciferase Assay System (Promega) at the indicated time
postinfection.
Figure 2 Expression of EGFP on BHK-21 cells. BHK-21 cells were
cotransfected with pVaXJ-EGFP+pVaE+pVaC, pVaXJ-EGFP+pVaE,
pVaXJ-EGFP+pVaC, respectively, and the expressions of EGFP were
observed through scanned by an inverted fluorescence microscope
(400×) at 24 hours postinfection. The BHK-21 cells without any
transfection (Mock) were used as control.
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Sindbis virus-derived DNA vector to express heteroge-
nous genes in host cells.
DNA-based vector derived from alphavirus can be
initiated by transfection of plasmid DNA [4,19]. In this
strategy, full-length 5’-capped RNAs are transcribed in
the nucleus using a polymerase II promoter, and trans-
ported to the cytoplasm. Then autocatalytic amplifica-
tion of the vector, proceeds according to the Sindbis
virus replication cycle and results in expression of the
heterologous gene. Thus, as a double-stranded DNA,
DNA-based vector can be directly transfected into the
host cells dispensing with the process of in vitro tran-
scription and mRNA capping, which is required for the
transfection of previously described Sindbis virus-
derived RNA vectors. In this study, we have constructed
DNA-based vector pVaXJ from XJ-160 virus, which
could efficiently express reporter genes in the trans-
fected cells. The XJ-160 virus-derived DNA vectors
described here increase the utility of alphavirus-based
vector systems in general and also provide a vector with
broad potential applications for genetic immunization.
The SINV-derived replicons lacking viral structural
genes are suicide vectors, incapable of packaging into
infectious particles and causing productive infection. To
obtain viable particles, vector replicon can be packaged
into infectious particles by cotransfection of cultured
cells with a defective helper vector, which provides the
virion structural proteins in trans [20]. Two principal
strategies are being performed for construction of DH
vector: (i) engineering recombinant plasmid that
expresses viral subgenomic RNAs (NH2-C-E3-E2-6K-
E1-COOH) and (ii) developing two DH vectors, one
that expresses the capsid protein and a second that
expresses the viral glycoproteins. High levels of expres-
sion of heterologous genes were achieved by using both
of two methods. However, it is not clear which of the
two SPs or both is necessary for SINV-derived vector to
express heterologous coding sequences. In this investiga-
tion, based on the XJ-160 virus-derived DNA vector, our
findings clearly prove that glycoprotein is enough for
Sindbis virus-derived DNA vector to express heteroge-
nous genes in host cells. The method of gene expression
from Sindbis virus-based DNA vector only co-trans-
fected with envelop E gene increases the conveniency
and the utility of alphavirus-based vector systems in
general.
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